Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Cancer    crawled date : 2022 - 11 - 08    save search

Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)
Published: 2022-11-08 (Crawled : 22:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.69% C: -0.23%
REGN | News | $906.55 -0.09% -0.08% 370K twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 2.48% C: -1.07%

libtayo treatment fda lung approved cancer
Global Liquid Biopsy Market Report 2022: Increased Awareness Regarding Cancer Boosts 13.77% Annual Growth
Published: 2022-11-08 (Crawled : 21:00) - prnewswire.com
BIO | $278.21 -2.48% 0.0% 210K twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 6.91% C: 6.14%
NTRA | News M | $91.47 0.47% 0.47% 810K twitter stocktwits trandingview |
Health Services
| | O: 3.06% H: 0.43% C: -15.25%
MYGN | $18.61 0.05% 0.05% 480K twitter stocktwits trandingview |
Health Technology
| | O: -0.78% H: 5.43% C: 3.08%
ILMN | $122.74 -1.38% -1.4% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -1.08% H: 1.4% C: 0.07%
BIOC | $0.4349 -10.32% 750K twitter stocktwits trandingview |
Health Services
| | O: -1.24% H: 3.8% C: -6.33%

global report cancer growth market
Instil Bio Announces Poster Presentations of CoStAR Platform at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-11-08 (Crawled : 20:00) - biospace.com/
TIL | $10.53 -2.05% -2.09% 5.1K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.79% H: 1.18% C: -3.92%

immunotherapy meeting cancer platform
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
Published: 2022-11-08 (Crawled : 20:00) - biospace.com/
PRPH | $5.12 -0.78% -0.78% 16K twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 2.34% C: 1.05%

collaboration cancer
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
Published: 2022-11-08 (Crawled : 19:00) - biospace.com/
CNBX | $0.0124 5.88% 20K twitter stocktwits trandingview |
Manufacturing
| | O: 0.76% H: 0.25% C: 0.0%

biopharma immunotherapy cancer market
Breast Cancer Liquid Biopsy Testing Devices Market Size to Grow by USD 730.4 Mn, CTCs and Circulating Nucleic Acids to be Largest Revenue-generating Type Segment - Technavio
Published: 2022-11-08 (Crawled : 19:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.91% C: -1.38%
BIOC | $0.4349 -10.32% 750K twitter stocktwits trandingview |
Health Services
| | O: -1.24% H: 3.8% C: -6.33%

breast cancer market
Cancer/Tumor Profiling Market worth $16.0 billion by 2027 - Exclusive Report by MarketsandMarkets™
Published: 2022-11-08 (Crawled : 16:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 1.31% C: -0.42%
QGEN | $41.52 -0.88% 0.0% 820K twitter stocktwits trandingview |
Health Technology
| | O: 4.08% H: 3.3% C: 1.47%
QGEN | $41.52 -0.88% 0.0% 820K twitter stocktwits trandingview |
Health Technology
| | O: 4.08% H: 3.3% C: 1.47%
NSTG M | $0.1053 -37.43% -0.19% 0 twitter stocktwits trandingview |
Health Technology
| | O: -17.68% H: 2.9% C: -18.05%
ILMN | $122.74 -1.38% -1.4% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.37% H: 2.1% C: 0.02%
HTGM | $0.48 -20.0% -26.08% 0 twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 7.06% C: 3.06%
GH | News 4 | $18.1 4.38% 4.2% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -0.85% H: 1.54% C: -5.24%

report market cancer
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Published: 2022-11-08 (Crawled : 14:20) - biospace.com/
ANIX | $3.1 0.98% 0.97% 360K twitter stocktwits trandingview |
Health Technology
| | O: -1.5% H: 2.67% C: -1.15%

vaccine breast symposium trial presentation cancer
Glycotope Presents GlycoTarget Platform and New Data on Platform-Derived anti-LYPD3 Antibody at 2022 Society for Immunotherapy of Cancer (SITC) Meeting Glycotope GmbH announces that it will present new...
Published: 2022-11-08 (Crawled : 09:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.97% H: 0.0% C: 0.0%

immunotherapy antibody meeting cancer platform
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.